The Breast Cancer Diagnostics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Breast Cancer Diagnostics Market?
The market size of the breast cancer diagnostics has seen significant growth recently. The market is projected to increase from $4.68 billion in 2024 to $5.04 billion in 2025, with a compound annual growth rate (CAGR) of 7.9%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Breast Cancer Diagnostics Industry?
The Breast Cancer Diagnostics Global Market is projected to reach $6.91 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.2%.
Download Your Free Sample of the 2025 Breast Cancer Diagnostics Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Breast Cancer Diagnostics Market?
The key drivers in the breast cancer diagnostics market are:
• Increasing implementation of personalized medicine in breast cancer diagnosis
• Growing utilization of liquid biopsies for diagnosing breast cancer
• Rising adoption of 3D mammography (tomosynthesis) in breast cancer diagnostics
• Advances in AI and machine learning applications for breast cancer diagnosis and telemedicine usage for remote consultations.
Global Market Segmentation: Identifying Major Breast Cancer Diagnostics Industry Segments
The breast cancer diagnostics market covered in this report is segmented –
1) By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types
2) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies
3) By Cancer Type: BRCA Breast Cancer, ER And PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Other Cancer Types
4) By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies
5) By End Users: Hospitals And Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers
Pre-order the 2025 Breast Cancer Diagnostics Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Breast Cancer Diagnostics Market?
The key trends in the breast cancer diagnostics market are:
• The future of the market is likely to be influenced by personalized medicine advancements.
• Liquid biopsies represent an important emerging trend for this sector.
• Innovations in AI and machine learning are expected to shape the market's future.
• There is also an increasing trend towards telemedicine and remote consultations.
Who Are the Top Competitors & Leading Players in the Breast Cancer Diagnostics Market?
Major companies in the breast cancer diagnostics market are:
• Abbott Laboratories
• Myriad Genetics Inc.
• Hologic Inc.
• Koninklijke Philips N.V.
• Fujifilm Holdings Corporation
• GE Healthcare
• Thermo Fisher Scientific Inc.
• Siemens AG
• NanoString Technologies Inc.
• Gamma Medica Inc.
• Aurora Imaging Technology Inc.
• Dilon Technologies Inc.
• Exact Sciences Corporation
• F. Hoffmann-La Roche Ltd
• Micrima Limited
• Provista Diagnostics Inc.
• Leica Biosystems Nussloch GmbH
• bioTheranostics Inc.
• Bio-Rad Laboratories Inc.
• Illumina Inc.
• Biocept Inc.
• Epigenomics AG
• AstraZeneca plc
• Quest Diagnostics Incorporated
• Agilent Technologies Inc.
• Cepheid
• Guardant Health Inc.
• Invitae Corporation
• Natera Inc.
• NeoGenomics Laboratories Inc.
• Oncocyte Corporation
• PerkinElmer Inc.
• Sysmex Corporation
• Veracyte Inc.
Regional Dominance: Which Area Leads the Global Breast Cancer Diagnostics Market?
North America was the largest region in the breast cancer diagnostics market in 2023
